| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |